The board of directors of Sun Pharma approved the appointment of Goenka and Bijapurkar as additional independent directors on the board of the company, with effect from May 21, 2021, to hold office up to the ensuing 29th annual general meeting of the company, Sun Pharma said in a regulatory filing.How to protect and exponentially Grow your investment portfolio during economic boom or bust, How learn stock market, How to earn money in stock market,earn money from home .
Sun Pharma appoints Pawan Goenka, Rama Bijapurkar as additional independent directors
The board of directors of Sun Pharma approved the appointment of Goenka and Bijapurkar as additional independent directors on the board of the company, with effect from May 21, 2021, to hold office up to the ensuing 29th annual general meeting of the company, Sun Pharma said in a regulatory filing.
Subscribe to:
Post Comments (Atom)
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment